Geode Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103M Buy
989,453
+54,600
+6% +$5.7M 0.01% 1003
2025
Q1
$109M Buy
934,853
+22,315
+2% +$2.6M 0.01% 930
2024
Q4
$77.2M Buy
912,538
+4,079
+0.4% +$345K 0.01% 1158
2024
Q3
$81.7M Buy
908,459
+23,564
+3% +$2.12M 0.01% 1126
2024
Q2
$71.2M Buy
884,895
+39,488
+5% +$3.18M 0.01% 1128
2024
Q1
$67.5M Buy
845,407
+23,103
+3% +$1.84M 0.01% 1163
2023
Q4
$65.5M Buy
822,304
+43,809
+6% +$3.49M 0.01% 1156
2023
Q3
$54.4M Buy
778,495
+68,727
+10% +$4.8M 0.01% 1178
2023
Q2
$51M Buy
709,768
+57,332
+9% +$4.12M 0.01% 1232
2023
Q1
$40.2M Buy
652,436
+27,847
+4% +$1.72M 0.01% 1341
2022
Q4
$48.2M Buy
624,589
+62,000
+11% +$4.78M 0.01% 1170
2022
Q3
$25.1M Buy
562,589
+30,837
+6% +$1.38M ﹤0.01% 1566
2022
Q2
$20.4M Sell
531,752
-4,272
-0.8% -$164K ﹤0.01% 1760
2022
Q1
$22.2M Buy
536,024
+28,539
+6% +$1.18M ﹤0.01% 1826
2021
Q4
$19.2M Buy
507,485
+16,055
+3% +$607K ﹤0.01% 1988
2021
Q3
$16.2M Buy
491,430
+8,180
+2% +$270K ﹤0.01% 2102
2021
Q2
$32.6M Buy
483,250
+14,663
+3% +$989K ﹤0.01% 1655
2021
Q1
$26.5M Buy
468,587
+41,286
+10% +$2.34M ﹤0.01% 1696
2020
Q4
$34.8M Buy
427,301
+9,745
+2% +$794K 0.01% 1367
2020
Q3
$29.8M Sell
417,556
-8,333
-2% -$594K 0.01% 1235
2020
Q2
$35M Buy
425,889
+14,639
+4% +$1.2M 0.01% 1099
2020
Q1
$24.2M Buy
411,250
+43,229
+12% +$2.54M 0.01% 1169
2019
Q4
$38M Buy
368,021
+24,385
+7% +$2.52M 0.01% 1118
2019
Q3
$6.96M Buy
343,636
+38,999
+13% +$789K ﹤0.01% 2181
2019
Q2
$7.84M Buy
304,637
+142,183
+88% +$3.66M ﹤0.01% 2104
2019
Q1
$2.31M Buy
162,454
+68,249
+72% +$971K ﹤0.01% 2776
2018
Q4
$265K Hold
94,205
﹤0.01% 3598
2018
Q3
$325K Hold
94,205
﹤0.01% 3594
2018
Q2
$301K Hold
94,205
﹤0.01% 3601
2018
Q1
$230K Hold
94,205
﹤0.01% 3647
2017
Q4
$527K Hold
94,205
﹤0.01% 3339
2017
Q3
$522K Buy
94,205
+21,511
+30% +$119K ﹤0.01% 3342
2017
Q2
$399K Buy
72,694
+14,891
+26% +$81.7K ﹤0.01% 3434
2017
Q1
$225K Buy
57,803
+5,156
+10% +$20.1K ﹤0.01% 3616
2016
Q4
$355K Buy
52,647
+3,517
+7% +$23.7K ﹤0.01% 3400
2016
Q3
$387K Buy
49,130
+805
+2% +$6.34K ﹤0.01% 3351
2016
Q2
$364K Buy
48,325
+13,862
+40% +$104K ﹤0.01% 3352
2016
Q1
$296 Buy
+34,463
New +$296 ﹤0.01% 3487